Skip to main content

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Top User Menu

  • CME
  • Register
  • Login
Advertisement

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum
  • (-) Slides (93)
Videos
Podcast
News Category
  • TCT (58)
  • Fellows (5)
  • LAA (4)
  • VEINS (2)
  • Aortovascular (1)
  • ESC (1)
  • ICI (1)
  • ISET (1)
  • SOLACI (1)
  • Coronary (31)
  • CAD Pharma (26)
  • ACS/AMI (13)
  • Left Atrial Appendage (11)
  • Stroke (5)
  • Clinical Cardiology (4)
  • Heart Rhythm (4)
  • Clinical Pharma (3)
  • Prevention (3)
  • Structural Heart (3)
  • Venous (2)
  • Heart Failure (1)
  • (-) 2016 (93)
Displaying 1 - 20 of 93
Sort: Relevancy | Date
Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?
Presentation TCT 2016

Should the New Oral Anticoagulants (vs Warfarin) Change the Equation of Triple Therapy vs LAA Closure?

Presenter: Martin W. Bergmann, Samir R. Kapadia, Harvey D. White
November 01, 2016
When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?
Presentation TCT 2016

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran
November 01, 2016
Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding
Presentation TCT 2016

Dosing Considerations of Oral Anticoagulant Therapy in the ACS and PCI Patient: Optimizing Efficacy While Minimizing Bleeding

Presenter: David P. Faxon, C. Michael Gibson
November 01, 2016
What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT
Presentation TCT 2016

What Is Known (and What Is Not) About Discontinuing Aspirin or Clopidogrel in Patients on Chronic Oral Anticoagulants Plus DAPT

Presenter: David P. Faxon, C. Michael Gibson, Freek W.A. Verheugt
November 01, 2016
The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT
Presentation TCT 2016

The Big Picture: Incremental Bleeding Risks in Patients Requiring Chronic Oral Anticoagulants Plus DAPT

Presenter: David P. Faxon, C. Michael Gibson, Christopher B. Granger
November 01, 2016
Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?
Presentation TCT 2016

Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven?

Presenter: Vivek Y. Reddy, Steven J. Yakubov, David R. Holmes Jr.
October 30, 2016
Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness)
Presentation TCT 2016

Meta-analysis and Synthesis of Watchman Trials: Relative Safety and Efficacy vs Warfarin and NOACs in Anticoagulant Indicated Patients (Including Cost-effectiveness)

Presenter: Vivek Y. Reddy, Steven J. Yakubov
October 30, 2016
Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!
Presentation TCT 2016

Start With a Three-way Debate: Bivalirudin Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Harvey D. White
October 30, 2016
Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!
Presentation TCT 2016

Start With a Three-way Debate: Heparin Plus Routine Use of GP IIb/IIIa Inhibitors Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann, Jorge F. Saucedo
October 30, 2016
Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!
Presentation TCT 2016

Start With a Three-way Debate: Heparin Monotherapy Is the Optimal Procedural Anticoagulant in STEMI Patients Undergoing Primary PCI!

Presenter: A. Michael Lincoff, Franz-Josef Neumann
October 30, 2016
Reversal of Chronic Anticoagulation: When, What, and How Effective?
Presentation TCT 2016

Reversal of Chronic Anticoagulation: When, What, and How Effective?

Presenter: Paul A. Gurbel, James A. Reiffel
October 30, 2016
Chronic Oral Anticoagulants: Limitations, Use Recommendations, and Investigational Agents
Presentation TCT 2016

Chronic Oral Anticoagulants: Limitations, Use Recommendations, and Investigational Agents

Presenter: Paul A. Gurbel, Christopher B. Granger
October 30, 2016
Antiplatelet Agents: Limitations, Use Recommendations, and Investigational Agents
Presentation TCT 2016

Antiplatelet Agents: Limitations, Use Recommendations, and Investigational Agents

Presenter: David J. Moliterno
October 30, 2016
Procedural Anticoagulants: Limitations, Use Recommendations and, Investigational Agents
Presentation TCT 2016

Procedural Anticoagulants: Limitations, Use Recommendations and, Investigational Agents

Presenter: Paul A. Gurbel, Harvey D. White
October 30, 2016
How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy
Presentation Fellows 2016

How to Navigate the New Oral Anticoagulants and Deal With Triple Therapy

Presenter: Roxana Mehran
April 15, 2016
Outcomes of Patients With Acute MI Undergoing PCI Receiving an Oral Anticoagulant and DAPT
Presentation

Outcomes of Patients With Acute MI Undergoing PCI Receiving an Oral Anticoagulant and DAPT

Presenter: Larry R. Jackson
December 21, 2015
Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure
Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy
December 13, 2015
Is There a Role for Oral Anticoagulants After PCI?
Presentation TCT 2015

Is There a Role for Oral Anticoagulants After PCI?

Presenter: Eric R. Bates, Neal S. Kleiman, C. Michael Gibson
October 15, 2015
Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention
Presentation TCT 2015

Vorapaxar: Lessons From the Randomized Trials in ACS and for Secondary Prevention

Presenter: Eric R. Bates, Neal S. Kleiman, Ori Ben-Yehuda
October 15, 2015
Should You Bridge in Stented Patients Needing Surgery?
Presentation TCT 2015

Should You Bridge in Stented Patients Needing Surgery?

Presenter: Eric R. Bates, Neal S. Kleiman, David F. Kong
October 15, 2015

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Page 5
  • Next page ››
  • Last page Last »
Advertisement
Become a Member

Register for TCTMD ®

Membership Plans
Sign Up for Our Newsletter

Receive the the latest news, research, and presentations from major meetings right to your inbox.

TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting the next wave of innovation in research and education that will help doctors save and improve the quality of their patients’ lives. For more information, visit http://www.crf.org.

Main Navigation

  • News
  • Conferences
  • Slides
  • Videos
  • Podcasts
  • Fellows Forum
  • CV Team Forum
  • CME

Specialty Menu Navigation

  • COVID-19

  • Clinical

  • Coronary

  • Structural

  • Endovascular

  • Heart Failure

  • Heart Rhythm

  • Imaging & Physiology

  • Policy & Practice

Footer

  • Advertising & Sponsorships
  • About TCTMD ®
  • FAQs
  • Editorial Policy
  • Contact Us
  • About CRF ®
Digital Health Awards Winner - Spring 2017 eHealthcare Leadership Awards - 2018 Winner HON Code Certified
Copyright © 2026. TCTMD ® All rights reserved.
  • Privacy Policy
  • Terms of Use
Created by Constructive
Sign In

New at TCTMD? Register today!

Forgot Password

Forgot Your Password?

Enter the email you used to register to reset your password.

Search TCTMD
cme
CME TITLE
Sign up for our newsletter

Sign up to receive the most important cardiovascular news, research, and major meeting presentations.

Address
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Main navigation

  • News
    • Conference News
    • Features
    • Opinion
  • Conferences
  • Slides
  • Specialties
    • COVID-19
    • Clinical
    • Coronary
    • Structural
    • Endovascular
    • Heart Failure
    • Heart Rhythm
    • Imaging & Physiology
    • Policy & Practice
  • Podcasts
    • Heart Sounds
    • Rox Heart Radio
    • TCTMD Talking Points
    • Taking It To Heart
    • Heart Valve Matters
    • Hearts & Minds
  • Videos
    • All Videos
    • Interviews
    • Topical Discussions
    • On Record
    • Live Cases
    • Partner Content
  • Fellows Forum
  • CV Team Forum

Top User Menu

  • CME
  • Register
  • Login

Search TCTMD

Submit an Event
< >

Become a PREMIUM MEMBER or LOG IN to view exclusive content

This content is available for meeting attendees and/or Platinum Members

REGISTER for free or LOG IN to view this content

Now Playing